Tag Archives: Eli Lilly

Merck, Lilly, Pfizer: One for All and All for One

By Oriana Schwindt | Published: February 24, 2010
Just a month after Andrew Witty’s announcement that GSK will make more than 13,500 of its malaria compounds available to all, Pfizer, Merck, and Eli Lilly have thrown their do-gooder hats into the ring as well. Together, the three drug giants will pull together an undisclosed dollar amount in seed funding and create the independent, non-profit [...]
Posted in Strategy | Also tagged , , , , , , | 1 Comment

HBA Names Woman of the Year

By Oriana Schwindt | Published: February 16, 2010
GSK’s Deirdre Connelly has been named the Healthcare Businesswomen’s Association’s Woman of the Year for 2010. Connelly, who just passed the one-year mark as president of GSK’s North American pharmaceuticals unit, is the 21st woman to win the organization’s “WOTY” award, which comes on the heels of another honor: She was ranked #37 in Fortune’s [...]
Posted in Corporate Responsibility, News, People, leadership | Also tagged , , , | Leave a comment

The Trouble with Transparency

By George Koroneos | Published: November 6, 2009
Guest blog by Jacky Law A couple of weeks ago I attended an industry awards dinner and had an interesting conversation with an eminent doctor who shall remain nameless. The doctor in question works in a highly specialized area and frequently talks about her research at conferences around the world. She always travels first-class and has [...]
Posted in Guest Blog, Strategy | Also tagged , , , , , , | Leave a comment

Lilly’s ImClone Makes NYC Its Home Base

By George Koroneos | Published: August 11, 2009
Yet another pharma firm is going to be calling New York City home. Late last month, Lilly announced that it would lease space at the Alexandria Center, to house the new research headquarters for ImClone Systems. ImClone will be the anchor tenant at Alexandria’s newest life science destination located in Manhattan’s East Side life science/medical [...]
Posted in Strategy | Also tagged , , , , , | 1 Comment

Amylin Drops 200 Sales Reps

By George Koroneos | Published: May 6, 2009
Image via Wikipedia Biotech firm Amylin, on Monday, announced that it would trim its sales force by 200, or about 35 percent of its total. The move is expected to save the company about $65 million by 2010, and comes on the heels of an announcement that the company asked FDA to consider a once-weekly injectable [...]
Posted in Strategy | Also tagged , , , , , , | Leave a comment